Navigation Links
ASTRO Names New Research Director, Health Policy Analyst
Date:9/18/2008

FAIRFAX, Va., Sept. 18 /PRNewswire-USNewswire/ -- The American Society for Therapeutic Radiology and Oncology has welcomed two new additions to its growing staff; Barbara Muth is ASTRO's new director of research and Jennifer Frazier joins the Society as a health policy analyst.

Ms. Muth brings nearly 20 years of healthcare research experience to ASTRO. Prior to joining ASTRO, she worked with the American Red Cross for eight years as the research manager, where she was responsible for prioritizing their research agenda, working with volunteers to establish practice and training guidelines, and designing health and safety studies. She has also held positions with the Lombardi Comprehensive Cancer Center at Georgetown University in Washington and Memorial Sloan-Kettering Cancer Center in New York, managing the NCI-funded National Hispanic Leadership Initiative on Cancer Project, which was the first comprehensive assessment of cancer risk factors among the major populations of Hispanic/Latino men and women in the United States. Also at Memorial Sloan-Kettering, Ms. Muth helped to design a patient navigation program to facilitate cancer detection and treatment for low-income patients. At ASTRO, Ms. Muth will be responsible for leading ASTRO's research team in promoting research, disseminating research results, administrating ASTRO's extensive awards and grants program, and overseeing ASTRO's Research Council and the committees within it.

Ms. Frazier is the newest addition to ASTRO's Health Policy Department. She holds a Master of Public Health degree from the University of Florida at Gainesville, Fla., and before joining ASTRO, she completed a fellowship at the National Cancer Institute in health communications where she helped to plan, develop and promote cancer education programs and materials for the public, cancer patients and health professionals. She has also held a research assistant position with the University of Florida Shands Cancer Center where she worked on two studies examining the impact of cancer on the quality of life of survivors and their families. At ASTRO, Ms. Frazier will be responsible for monitoring the impact of health policy regulatory issues on radiation oncology practices, analyzing health policy regulatory proposals and providing technical assistance to members and their practice managers on practice-related issues. Ms Frazier will also serve as staff liaison to the Emerging Technology Committee and as ASTRO's staff representative to the American Medical Association's Relative Value Update committee.

"We are very excited to have Barbara and Jennifer join our staff," Laura I. Thevenot, ASTRO's chief executive officer, said. "With both of their vast experience in various cancer and public health initiatives, they will be a great asset to the Society and to our members."

ASTRO is the largest radiation oncology society in the world, with more than 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.


'/>"/>
SOURCE American Society for Therapeutic Radiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Strategies for preventing gastrointestinal complications in severely burned patients
2. How to treat gastroesophageal adenocarcinom patients?
3. Groundbreaking cancer studies to be unveiled at ASTRO annual meeting
4. A new breakthrough in timing of urgent endoscopy for gastrointestinal bleeding patients
5. Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis
6. ASTRO selects pediatric oncologist as 2008 honorary member
7. SNM and ASTRO team up to advance molecular imaging and cancer research
8. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
9. Genomma Lab Internacional Acquires UNIGASTROZOL
10. Sports Luminaries Andre Agassi, Jerry Rice, Scottie Pippen, Helio Castrovenes, Richard Goose Gossage Among Those Named 2008 Great Sports Legends
11. MDCT, virtual gastroscopy and MPR images differentiate malignant and benign gastric ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... ... This Mother’s Day kicks off the start of an important week not just ... takes place May 8-May 14. , Throughout the celebration, the U.S. Department of ... their health a top priority. Women everywhere are being encouraged to take steps toward ...
(Date:5/6/2016)... MOOREFIELD, W.V. (PRWEB) , ... May 06, 2016 , ... ... by WestBow Press) shares accounts of dying patients who have allowed those holding vigil ... June E. Kuykendall, RN, BSN, CHPN, hopes to help readers spiritually and practically gain ...
(Date:5/5/2016)... Aliso Viejo, CA (PRWEB) , ... May 05, 2016 , ... ... use in Final Cut Pro X. Drag and drop a TransWipe preset between two ... project. Choose from smooth corner wipes to colored panels with customizable color and orientation ...
(Date:5/5/2016)... ... May 05, 2016 , ... Pivot ... the industry’s gold standard KLAS Performance Report, Epic Consulting 2016 - ... organizations that specialize in consulting services for electronic health record (EHR) solutions from ...
(Date:5/5/2016)... ... May 05, 2016 , ... Textile Exchange is ... (RWS) for public stakeholder review. The stakeholder review is an important opportunity for interested ... goals and delivers value to the wool industry., The RWS is intended to be ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016  It,s time for an upgrade. There are many medical recorders ... 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix ... a world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Multiple Myeloma ...  report to their offering.       ... Multiple Myeloma Market and Competitive Landscape Highlights ... pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma ...
Breaking Medicine Technology: